0
Sign In  | Subscribe

Hypertension Collection
 1-20 of 37 Articles
ACP Journal Club |  21 May 2013
Review: Carvedilol may reduce mortality more than other β1-selective β-blockers in systolic HF
PDFPDF
Ann Intern Med. 2013;158(10):JC3. doi:10.7326/0003-4819-158-10-201305210-02003
ACP Journal Club |  15 January 2013
Review: Intensive blood pressure control reduces stroke, but not mortality or MI, in type 2 diabetes
PDFPDF
Louise Moist, MD
Ann Intern Med. 2013;158(2):JC5-. doi:10.7326/0003-4819-158-2-201301150-02005
ACP Journal Club |  18 December 2012
Review: Low-quality evidence fails to show that antihypertensive drugs affect outcomes in mild hypertension
PDFPDF
James Brophy, MD, FRCP, PhD
Ann Intern Med. 2012;157(12):JC6-6. doi:10.7326/0003-4819-157-12-201212180-02006
ACP Journal Club |  18 December 2012
Review: Eplerenone is not more effective for reducing mortality than other aldosterone antagonists
PDFPDF
Ellis Lader, MD, FACC
Ann Intern Med. 2012;157(12):JC6-10. doi:10.7326/0003-4819-157-12-201212180-02010
ACP Journal Club |  16 October 2012
Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes
PDFPDF
Juan P. Brito, MD; Victor M. Montori, MD, MSc
Ann Intern Med. 2012;157(8):JC4-7. doi:10.7326/0003-4819-157-8-201210160-02007
ACP Journal Club |  20 December 2011
Review: Home and clinic BP have limited accuracy compared with ambulatory BP for diagnosing hypertension
PDFPDF
Ross D. Feldman, MD
Ann Intern Med. 2011;155(12):JC6-10. doi:10.7326/0003-4819-155-12-201112200-02010
ACP Journal Club |  21 June 2011
Candesartan did not improve clinical or functional outcomes in patients with acute stroke and elevated BP
PDFPDF
Rick Frieden, MD
Ann Intern Med. 2011;154(12):JC6-5. doi:10.7326/0003-4819-154-12-201106210-02005
ACP Journal Club |  21 June 2011
Review: Antihypertensive treatment prevents cardiovascular events and mortality in cardiovascular disease without hypertension
PDFPDF
Jay N. Cohn, MD
Ann Intern Med. 2011;154(12):JC6-6. doi:10.7326/0003-4819-154-12-201106210-02006
ACP Journal Club |  17 May 2011
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions
PDFPDF
Reem Mustafa, MD, MPH; Amit X. Garg, MD, PhD
Ann Intern Med. 2011;154(10):JC5-5. doi:10.7326/0003-4819-154-10-201105170-02005
ACP Journal Club |  17 May 2011
Review: Low-dose hydrochlorothiazide is not as effective as other antihypertensive drugs for reducing ambulatory BP in hypertension?
PDFPDF
Eugene Yang, MD, FACC
Ann Intern Med. 2011;154(10):JC5-8. doi:10.7326/0003-4819-154-10-201105170-02008
ACP Journal Club |  15 February 2011
Pharmacist–physician hypertension comanagement reduced 24-hour ambulatory blood pressure
PDFPDF
Brett D. Montgomery, MBBS, DCH, FRACGP
Ann Intern Med. 2011;154(4):JC2-9. doi:10.7326/0003-4819-154-4-201102150-02009
ACP Journal Club |  16 November 2010
Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD
PDFPDF
Chi-yuan Hsu, MD, MSc
Ann Intern Med. 2010;153(10):JC5-3. doi:10.7326/0003-4819-153-10-201011160-02003
ACP Journal Club |  19 October 2010
Benazepril plus amlodipine reduced CV events more than benazepril plus hydrochlorothiazide in hypertension with or without diabetes
PDFPDF
Srinivas Merugu, MD
Ann Intern Med. 2010;153(8):JC4-2. doi:10.7326/0003-4819-153-8-201010190-02002
ACP Journal Club |  20 July 2010
Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes
PDFPDF
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-4. doi:10.7326/0003-4819-153-2-201007200-02004
ACP Journal Club |  15 June 2010
Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors
PDFPDF
Michael Farkouh, MD, MSc
Ann Intern Med. 2010;152(12):JC6-9. doi:10.7326/0003-4819-152-12-201006150-02009
ACP Journal Club |  15 June 2010
Aspirin did not prevent vascular events or mortality in adults with a low ankle–brachial index
PDFPDF
A.C. Felix Burden, MD
Ann Intern Med. 2010;152(12):JC6-11. doi:10.7326/0003-4819-152-12-201006150-02011
ACP Journal Club |  18 May 2010
Good evidence supports use of ACE inhibitors in stable ischemic heart disease; little evidence exists for ARBs
PDFPDF
Vibhuti Singh, MD, MPH
Ann Intern Med. 2010;152(10):JC5-3. doi:10.7326/0003-4819-152-10-201005180-02003
ACP Journal Club |  16 February 2010
Review: Early treatment of a cardiovascular event with nitrates or ACE inhibitors reduces short-term mortality
PDFPDF
Jason Bradfield, MD; Kalyanam Shivkumar, MD, PhD
Ann Intern Med. 2010;152(4):JC2-3. doi:10.7326/0003-4819-152-4-201002160-02003
ACP Journal Club |  19 January 2010
Review: First-line low-dose thiazides and ACE inhibitors reduce mortality and morbidity in adults with hypertension
PDFPDF
Nirav R. Shah, MD, MPH; Gbenga Ogedegbe, MD, MPH, MS
Ann Intern Med. 2010;152(2):JC1-4. doi:10.7326/0003-4819-152-2-201001190-02004
ACP Journal Club |  17 November 2009
Review: Low BP targets do not reduce mortality or CV events in hypertension
PDFPDF
Finlay A. McAlister, MD
Ann Intern Med. 2009;151(10):JC5-6. doi:10.7326/0003-4819-151-10-200911170-02006
Advertisement

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)